Vancomycin-resistant enterococci risk factors

Revision as of 19:22, 14 December 2012 by Hardik Patel (talk | contribs)
Jump to navigation Jump to search

Vancomycin-resistant enterococci Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vancomycin-Resistant Enterococci from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vancomycin-resistant enterococci risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vancomycin-resistant enterococci risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onVancomycin-resistant enterococci risk factors

CDC on Vancomycin-resistant enterococci risk factors

enterococci risk factors in the news

on Vancomycin-resistant enterococci risk factors

Directions to Hospitals Treating Vancomycin-resistant enterococci

Risk calculators and risk factors for Vancomycin-resistant enterococci risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Prior treatment with antibiotics is common in nearly all patients colonized or infected with MDR enterococci. Clindamycin, cephalosporin,aztreonam, ciprofloxacin, aminoglycoside, and metronidazole use is equally or more often associated with colonization or infection with MDR enterococci than vancomycin use. Other risk factors include prolonged hospitalization, high severity of illness score, intraabdominal surgery, renal insufficiency, enteral tube feedings, and exposure to specific hospital units, nurses, or contaminated objects and surfaces within patient-care areas.

Risk Factors

The following persons are at an increased risk becoming infected with VRE:

  • Persons who have been previously treated with vancomycin and combinations of other antibiotics such as penicillin and gentamicin.
  • Persons who are hospitalized, particularly when they receive antibiotic treatment for long periods of time.
  • Persons with weakened immune systems such as patients in Intensive Care Units, or in cancer or transplant wards.
  • Persons who have undergone surgical procedures such as abdominal or chest surgery.
  • Persons with medical devices that stay in for some time such as urinary catheters or central intravenous catheters.

References

Template:WH

Template:WS